Cancer driver prioritization for functional analysis of potential actionable therapeutic targets is a significant challenge. Meta-analyses of mutated genes across different human cancer types for driver prioritization has reaffirmed the role of major players in cancer, including KRAS, TP53 and EGFR, but has had limited success in prioritizing genes with non-recurrent mutations in specific cancer types. Sleeping Beauty (SB) insertional mutagenesis is a powerful experimental gene discovery framework to define driver genes in mouse models of human cancers. Meta-analyses of SB datasets across multiple tumor types is a potentially informative approach to prioritize drivers, and complements efforts in human cancers. Here, we report the development of SB Driver Analysis, an in-silico method for defining cancer driver genes that positively contribute to tumor initiation and progression from population-level SB insertion data sets. We demonstrate that SB Driver Analysis computationally prioritizes drivers and defines distinct driver classes from end-stage tumors that predict their putative functions during tumorigenesis. SB Driver Analysis greatly enhances our ability to analyze, interpret and prioritize drivers from SB cancer datasets and will continue to substantially increase our understanding of the genetic basis of cancer.
Digital Object Identifier (DOI)
This work is licensed under a Creative Commons Attribution-Noncommercial 4.0 License
Citation / Publisher Attribution
Nucleic Acids Research, v. 46, issue 16, p. e94
Scholar Commons Citation
Newberg, Justin Y.; Black, Michael A.; Jenkins, Nancy A.; Copeland, Neal G.; Mann, Karen M.; and Mann, Michael B., "SB Driver Analysis: A Sleeping Beauty Cancer Driver Analysis Framework for Identifying and Prioritizing Experimentally Actionable Oncogenes and Tumor Suppressors" (2018). Oncologic Sciences Faculty Publications. 8.
Was this content written or created while at USF?